Cephalon GmbH Company Profile

16:01 EDT 24th March 2018 | BioPortfolio

Für die Betreuung der Märkte in Deutschland, Österreich und der Schweiz wurde 1997 in München die Cephalon GmbH gegründet. Im Jahr 2002 erfolgte der Umzug nach Martinsried bei München, einem der Hauptzentren der deutschen Biotechnologie.


Fraunhoferstr. 9a


Phone: 49 89 895570-0
Fax: 49 89 895570-15

News Articles [123 Associated News Articles listed on BioPortfolio]

Teva takes issue with EC charges of pay-for-delay deal with Cephalon

At a hearing today , Teva Pharmaceutical Industries says it "responded robustly" to charges from the European Commission's competition watchdog that it entered into an illegal "pay-for-delay" deal...

Teva rebuffs EU pay-for-delay charge at hearing

BRUSSELS (Reuters) - Israeli drugmaker Teva rebuffed EU antitrust charges of making an illegal deal with rival Cephalon to delay selling a cheaper generic version of the latter's sleep disorder drug ...

Teva denies wrongdoing in Cephalon pay-to-delay deal hearing

Teva has denied allegations from the European Commission (EC) that it engaged in illegal anti-competitive pay-to-delay tactics to maintain its market share in the sleep disorder drug space at a hearin...

Original-Research: Medigene AG (von EQUITS GmbH): Kaufen

Original-Research: Medigene AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu Medigene AG Unternehmen: Medigene AG ISIN: DE000A1X3W00 Anlass der Studie: Übernahme-Angebot Empfehlung: Kaufen Kursz...

NexWafe GmbH schließt Finanzierung in Höhe von 8 Millionen Euro ab

NexWafe GmbH, ein Spin-off des Fraunhofer ISE, das eine bahnbrechende Technologie zur epitaktischen Herstellung von Siliziumwafern für Photovoltaik kommerzialisiert, gab heute den Abschluss einer F...

Gerresheimer-Aktie: Dividendenerhöhung auch für 2018? Kaufempfehlung

Frankfurt am Main - Gerresheimer-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, nehmen in einer aktuellen Aktienanalyse die Coverage....

Original-Research: Valneva (von First Berlin Equity Research GmbH): BUY

Original-Research: Valneva - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Valneva Unternehmen: Valneva ISIN: FR0004056851 Anlass der Studie: 9M/17-Erge...

Original-Research: PHARMING (von First Berlin Equity Research GmbH): BUY

Original-Research: PHARMING - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu PHARMING Unternehmen: PHARMING ISIN: NL0010391025 Anlass der Studie: Update ...

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Postoperative Corneal Asphericity in Low, Moderate, and High Myopic Eyes After Transepithelial PRK Using a New Pulse Allocation.

To evaluate the postoperative asphericity in low, moderate, and high myopic eyes after combined transepithelial photorefractive keratectomy and SmartSurfACE treatment (SCHWIND eye-tech-solutions GmbH,...

Reliability of a Skin Diagnostic Device in Assessing Hydration and Erythema.

To examine the reliability of a skin diagnostic device, the SD202 (Courage+Khazaka GmBH, Cologne, Germany), in assessing hydration and erythema of periwound skin and pressure injury-prone areas.

Clinical Trials [47 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg

The objective of this study was to investigate the bioequivalence of Mylan modafinil 200 mg tablets to Cephalon Provigil® 200 mg tablets following a single, oral 200 mg (1 x 200 mg) dose ...

Substudy to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)

The substudy is a multicenter, open-label study consisting of a subset of the patients in Cephalon study C18083/3064/NL/MN who are receiving the investigational treatment (BR), for the pur...

Companies [536 Associated Companies listed on BioPortfolio]

Cephalon GmbH

Für die Betreuung der Märkte in Deutschland, Österreich und der Schweiz wurde 1997 in München die Cephalon GmbH gegründet. Im Jahr 2002 erfolgte der Umzug nach Martinsried bei München, einem der...


Cephalon seeks to discover, develop and market innovative products to treat neurological and sleep disorders, cancer, and pain. The company is committed to providing patients and the medical community...

Cephalon, Inc.

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

More Information about "Cephalon GmbH" on BioPortfolio

We have published hundreds of Cephalon GmbH news stories on BioPortfolio along with dozens of Cephalon GmbH Clinical Trials and PubMed Articles about Cephalon GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cephalon GmbH Companies in our database. You can also find out about relevant Cephalon GmbH Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record